共 176 条
[1]
Vestbo J(2013)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 187 347-365
[2]
Hurd SS(2010)Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity COPD 7 428-437
[3]
Agusti AG(2015)Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD Respir Med 109 785-802
[4]
Jones PW(2010)Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation Chest 138 32-38
[5]
Vogelmeier C(2013)Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study Circulation 127 1503-1511
[6]
Anzueto A(2014)Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment Expert Rev Respir Med 8 731-749
[7]
Deesomchok A(2014)Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial BMC Pulm Med 14 209-2558
[8]
Webb KA(2017)ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD Int J Chron Obstr Pulm Dis 12 2545-1361
[9]
Forkert L(2014)Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease Ann Am Thorac Soc 11 1351-242
[10]
Lam YM(2009)Tiotropium induced bronchodilation and protection from dynamic hyperinflation is independent of extent of emphysema in COPD Pulm Pharmacol Ther 22 237-840